Related Experiment Videos
Brief communication: Serum zinc concentration: an unreliable parameter for diagnosing bronchogenic carcinoma
Journal of the National Cancer Institute
|October 1, 1973
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Effects of alternative feed additives to medicinal zinc oxide on productivity, diarrhoea incidence and gut development in weaned piglets.
Animal : an international journal of animal bioscience·2020
Evaluation of the feeding value of Dichrostachys cinerea pods for fattening pigs in Cuba.
Tropical animal health and production·2017
Neurotoxic effects of MDMA (ecstasy) on the developing rodent brain.
Developmental neuroscience·2010
BDNF downregulates 5-HT(2A) receptor protein levels in hippocampal cultures.
Neurochemistry international·2009
Cancer rarity and mortality: Evidence from a nationwide cohort study.
Journal of the National Cancer Institute·2026
Matched targeted therapy use after broad genomic profiling in advanced Non-Small cell lung cancer.
Journal of the National Cancer Institute·2026
Evaluating the incidence and predictors of chronic opioid use in early survivorship for patients with diffuse large B-cell lymphoma.
Journal of the National Cancer Institute·2026
Predictive validity of a 10-item frailty index based on a comprehensive geriatric assessment (FI-CGA-10) in older Japanese adults with cancer.
Journal of the National Cancer Institute·2026
Association between genomic classifier scores and initial management of localized prostate cancer in the United States.
Journal of the National Cancer Institute·2026
Timing of mental disorders in relation to cancer-specific mortality in cancer patients.
Journal of the National Cancer Institute·2026
Omitting axillary dissection in breast cancer patients with one to two positive sentinel nodes undergoing mastectomy: a retrospective and prospective cohort study with a target trial emulation.
International journal of surgery (London, England)·2026
DESTINY-Lung06: trastuzumab deruxtecan and pembrolizumab as first-line treatment for HER2-overexpressing, PD-L1 TPS <50% NSCLC.
Future oncology (London, England)·2026
Tibolone Use Associated With Elevated Hepatocellular Carcinoma Risk: Findings From a Nationwide Cohort.
International journal of cancer·2026
Through beta2 or not through beta2-That's the question.
Cell metabolism·2026